BrOMOVULONE-III
Compound with spectra: 1 NMR, and 1 MS (GC)
| SpectraBase Compound ID | 1VdSVqnc0Iu |
|---|---|
| InChI | InChI=1S/C21H29BrO4/c1-3-4-5-6-9-12-15-21(25)16-18(22)20(24)17(21)13-10-7-8-11-14-19(23)26-2/h7,9-10,12-13,16,25H,3-6,8,11,14-15H2,1-2H3/b10-7+,12-9-,17-13+/t21-/m1/s1 |
| InChIKey | SEUGRXZAXYVQIH-MNSXJSHLSA-N |
| Mol Weight | 425.36 g/mol |
| Molecular Formula | C21H29BrO4 |
| Exact Mass | 424.124922 g/mol |
| Enantiomer InChIKey | SEUGRXZAXYVQIH-NSADSDBKSA-N |
| Racemate InChIKey | SEUGRXZAXYVQIH-QVOMYVINSA-N |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | G4-67-545-7 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- Bromoclavulone III
IODOVULONE-III
8-Carbomethoxy-bicyclo(5.3.1)undeca-1,3,5,8-tetraen-10-one
CLAVATADINE_D;N-(5-{[AMINO-(IMINO)-METHYL]-AMINO}-PENTYL)-7,9-DIBROMO-8-OXO-1-OXA-2-AZASPIRO-[4.5]-DECA-2,6,9-TRIENE-3-CARBOXAMIDE
(2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxo-1-cyclohex-2-enyl)-3-methylpenta-2,4-dienoic acid methyl ester
2,4-Pentadienoic acid, 5-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-, methyl ester, (R)-(Z,E)-
(+)-(S)-ABSCISIC-ACID-METHYLESTER
(2Z,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxo-1-cyclohex-2-enyl)-3-methylpenta-2,4-dienoic acid methyl ester
2-Oxabicyclo[3.2.0]hept-3-ene, 3,7,7-trimethyl-1-(3-methyl-1,3-butadienyl)-, (Z)-
2-Oxabicyclo[3.2.0]hept-3-ene, 3,7,7-trimethyl-1-(3-methyl-1,3-butadienyl)-, (E)-
| Title | Journal or Book | Year |
|---|---|---|
| New Prostanoids with Cytotoxic Activity from Taiwanese Octocoral Clavularia viridis | Journal of Natural Products | 2004 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.